Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study
Journal Article
Overview
publication date
- December 1, 2021
has subject area
- Bone Diseases, Developmental - Achondroplasia
- Bone Diseases, Developmental - Achondroplasia
- Child
- Environment and Public Health - Double-Blind Method
- Genetic Diseases, Inborn - Achondroplasia
- Health Care Evaluation Mechanisms - Double-Blind Method
- Health Care Evaluation Mechanisms - Treatment Outcome
- Health Services Administration - Treatment Outcome
- Hormones, Hormone Substitutes, and Hormone Antagonists - Natriuretic Peptide, C-Type
- Humans
- Investigative Techniques - Double-Blind Method
- Methods - Double-Blind Method
- Peptides - Natriuretic Peptide, C-Type
- Prognosis - Treatment Outcome
Date in CU Experts
- March 26, 2026 3:33 AM
Full Author List
- Savarirayan R; Tofts L; Irving M; Wilcox WR; Bacino CA; Hoover-Fong J; Font RU; Harmatz P; Rutsch F; Bober MB
author count
- 31
citation count
- 77
published in
- Genetics in Medicine Journal
Other Profiles
International Standard Serial Number (ISSN)
- 1098-3600
Electronic International Standard Serial Number (EISSN)
- 1530-0366
Digital Object Identifier (DOI)
Additional Document Info
start page
- 2443
end page
- 2447
volume
- 23
issue
- 12